Intuitive Surgical Remains Too Richly Valued

  In my April, June, and July 2022 Intuitive Surgical (ISRG) posts, I deemed shares to be attractively valued and disclosed the purchase of additional shares. In subsequent ISRG posts that are accessible through the FFJ Archives, however, I have disclosed my decision not to add to my exposure because I felt shares were overvalued. [...]

By |April 20th, 2024|Equity Investing|Comments Off on Intuitive Surgical Remains Too Richly Valued

Do Not Let Genuine Parts’ Dividend King Status Influence Your Investment Decision

  Genuine Parts' (GPC) has grown its dividend for 68 consecutive years thereby qualifying it for Dividend King status. Unfortunately, some investors base their investment decisions primarily/solely on dividend metrics. Do not let its Dividend King status influence your investment decision! Focus on the company's underlying fundamentals, competitive strengths, risk, and total potential long-term shareholder [...]

By |April 19th, 2024|Equity Investing|Comments Off on Do Not Let Genuine Parts’ Dividend King Status Influence Your Investment Decision

No Margin Of Safety in Goldman Sachs’ Valuation

I last reviewed Goldman Sachs (GS) in this October 23, 2023 post at which time the most recent financial results were for Q3 and YTD2023. Based on my analysis, I concluded that the firm's stumble had created a buying opportunity. Fast forward to April 15, 2024 and we now have Q1 2024 results. I, therefore, [...]

By |April 16th, 2024|Equity Investing|Comments Off on No Margin Of Safety in Goldman Sachs’ Valuation

Impressive Performance By BlackRock Continues

The asset manager industry is highly fragmented and most asset managers should not, for a variety of reasons, even exist. At the opposite end of the spectrum, however, impressive performance by BlackRock (BLK) continues thereby increasing the probability of it benefiting from inevitable industry consolidation. One of the conclusions in PwC's '2023 Global Asset and [...]

By |April 15th, 2024|Equity Investing|Comments Off on Impressive Performance By BlackRock Continues

Zoom Video Communications Exposure Increased

I last reviewed Zoom Video Communications (ZM) in this November 21, 2023 post at which time the most current results were for Q3 and YTD2024. On February 26, while in transit to British Columbia for a ski trip, ZM released its Q4 and FY2024 results. Now that I have had the time to analyze ZM's [...]

By |April 10th, 2024|Equity Investing|Comments Off on Zoom Video Communications Exposure Increased

Increased Exposure To Veeva Systems

In my March 21 post, I disclosed the addition of Veeva Systems (VEEV) to the FFJ Portfolio. When I wrote that post, I had recently returned from a ski trip. Shares were trading at ~$230 and I deemed shares to be at the top end of fair valuation. I, however, had initiated a 100 share [...]

By |April 9th, 2024|Equity Investing|Comments Off on Increased Exposure To Veeva Systems

Paychex Exposure Increased

  I last reviewed Paychex (PAYX) in this December 21, 2023 post at which time Q2 and YTD2024 results and an update to the FY2024 outlook had just been released. With the release of Q3 results and updated FY2024 outlook on April 2, I revisit this existing holding. Business Overview A Business Overview is provided [...]

By |April 3rd, 2024|Equity Investing|Comments Off on Paychex Exposure Increased
Go to Top